{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:45:22Z","timestamp":1787748322903,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jns.2021.117537","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T12:56:52Z","timestamp":1623761812000},"page":"117537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia"],"prefix":"10.1016","volume":"427","author":[{"given":"Tommaso","family":"Romagnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Ortolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana Maria","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Seripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Dalla","family":"Nora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Capatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Brombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117537_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-150451","article-title":"Dysregulation and diagnostic potential of microRNA in Alzheimer\u2019s disease","volume":"49","author":"Pan","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2021.117537_bb0010","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment: ten years later","volume":"66","author":"Petersen","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.117537_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00115","article-title":"Impaired Amyloid beta clearance: a potential link between atherosclerosis and Alzheimer\u2019s disease","volume":"7","author":"Gupta","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2021.117537_bb0020","series-title":"HDL Proteome and Alzheimer\u2019s Disease: Evidence of a Link","volume":"9","author":"Marsillach","year":"2020"},{"key":"10.1016\/j.jns.2021.117537_bb0025","doi-asserted-by":"crossref","first-page":"6695796","DOI":"10.1155\/2021\/6695796","article-title":"Connection between the altered HDL antioxidant and anti-inflammatory properties and the risk to develop Alzheimer\u2019s disease: a narrative review","volume":"2021","author":"Zimetti","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jns.2021.117537_bb0030","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/ATVBAHA.108.163998","article-title":"Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife","volume":"28","author":"Singh-Manoux","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jns.2021.117537_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer\u2019s disease\u2606","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2021.117537_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00039","volume":"7","author":"Jomard","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jns.2021.117537_bb0045","doi-asserted-by":"crossref","first-page":"39532","DOI":"10.1074\/jbc.M204855200","article-title":"Mildly acidic pH activates the extracellular molecular chaperone clusterin","volume":"277","author":"Poon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2021.117537_bb0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/exnr.1998.6892","article-title":"Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer\u2019s disease","volume":"154","author":"Lidstr\u00f6m","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2021.117537_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0169-328X(92)90148-5","article-title":"Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia","volume":"15","author":"May","year":"1992","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.jns.2021.117537_bb0060","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","article-title":"Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms","volume":"48","author":"Nilselid","year":"2006","journal-title":"Neurochem. Int."},{"issue":"Pt 1","key":"10.1016\/j.jns.2021.117537_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj2930027","article-title":"The cerebrospinal-fluid soluble form of Alzheimer\u2019s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex","volume":"293","author":"Ghiso","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.jns.2021.117537_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3160671","article-title":"Apolipoprotein J and Alzheimer\u2019s amyloid beta solubility","volume":"316","author":"Matsubara","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.jns.2021.117537_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1995.1080","article-title":"Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress","volume":"136","author":"Oda","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2021.117537_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00504","article-title":"Clusterin is required for \u03b2-amyloid toxicity in human iPSC-derived neurons","volume":"12","author":"Robbins","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2021.117537_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","article-title":"Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment","volume":"59","author":"Thambisetty","year":"2012","journal-title":"Neuroimage."},{"key":"10.1016\/j.jns.2021.117537_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050237","article-title":"No diagnostic value of plasma clusterin in Alzheimer\u2019s disease","volume":"7","author":"Silajd\u017ei\u0107","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.117537_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11011-018-0325-0","article-title":"Association between clusterin concentration and dementia: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jns.2021.117537_bb0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2021.117537_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2021.117537_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2021.117537_bb0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Contributors, NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2021.117537_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117537_bb0125","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2021.117537_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist."},{"key":"10.1016\/j.jns.2021.117537_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1300\/J018v05n01_09","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter version","volume":"5","author":"Sheikh","year":"1986","journal-title":"Clin. Gerontol."},{"key":"10.1016\/j.jns.2021.117537_bb0140","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer\u2019s disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2021.117537_bb0145","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/15672050113106660162","article-title":"Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer\u2019s disease","volume":"10","author":"Mullan","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jns.2021.117537_bb0150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2021.117537_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/mcne.1994.1027","article-title":"Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines","volume":"5","author":"Zwain","year":"1994","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jns.2021.117537_bb0160","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/oxfordjournals.jbchem.a124070","article-title":"The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement","volume":"113","author":"Choi-Miura","year":"1993","journal-title":"J. Biochem."},{"key":"10.1016\/j.jns.2021.117537_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ars.2020.8076","article-title":"Inflammation in neurological disorders: the thin boundary between brain and periphery","volume":"33","author":"Cervellati","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jns.2021.117537_bb0170","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron."},{"key":"10.1016\/j.jns.2021.117537_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt118","article-title":"Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer\u2019s disease","volume":"4","author":"Eikelenboom","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jns.2021.117537_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00179","article-title":"Plasma clusterin and the CLU gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients","volume":"8","author":"Cai","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2021.117537_bb0185","doi-asserted-by":"crossref","first-page":"P198","DOI":"10.1016\/j.jalz.2013.05.355","article-title":"P1-133: clusterin: an early biomarker for Alzheimer\u2019s disease?","volume":"9","author":"van Dijk","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2021.117537_bb0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-150036","article-title":"Clusterin levels in plasma predict cognitive decline and progression to Alzheimer\u2019s disease","volume":"46","author":"Jongbloed","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2021.117537_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2021.117537_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","article-title":"The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy","volume":"45","author":"Yu","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jns.2021.117537_bb0205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcp.22836","article-title":"Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain","volume":"227","author":"Kim","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jns.2021.117537_bb0210","article-title":"Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer\u2019s disease","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:08Z","timestamp":1758383888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0022510X21002318"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117537","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117537"}}